Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl-coenzyme a reductase inhibitor treatment of combined dyslipidemia.

Abstract
No abstract available

This publication has 0 references indexed in Scilit: